glp-1 drugs approved for weight loss Safety Check List of approved and pending

Nissen says its results are likely to steer prescribers and patients toward favoring a dual agonist like tirzepatide

However, in the last twenty years drug development targeting the glucagon-like peptide 1 receptor (GLP-1R) has opened a new window of opportunity for reliable, significant medical weight loss at tolerable doses 2 (Figure 1)

Understanding Semaglutide What are Ozempic and Wegovy

As shown by Sun et al., treatment with GLP-1RAs reshaped gut microbial composition by increasing the abundance of beneficial genera such as Lactobacillus and Bifidobacterium

10.1007/s11481-024-10142-w 19 DruckerD

Adjudicated four-component major adverse cardiovascular event (MACE-4 events